Prospective evaluation of concomitant tumour bed boost with whole breast irradiation in patients with locally advanced breast cancer undergoing breast-conserving therapy

Breast

Volumn 17, Issue 1, 2008, Pages 64-70

  Jalali, Rakesh ^a   Malde, Rohit ^a   Bhutani, Ritu ^a   Budrukkar, Ashwini ^a   Badwe, Rajendra ^a   Sarin, Rajiv ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

Breast cancer; Breast conserving therapy; Concomitant boost; Locally advanced

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL;

ADJUVANT THERAPY; ADULT; ADVANCED CANCER; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CLINICAL PRACTICE; COHORT ANALYSIS; CONTROLLED STUDY; DESQUAMATION; ESTHETICS; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEALTH CARE ACCESS; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RESEARCH; MULTIPLE CYCLE TREATMENT; PARTIAL MASTECTOMY; PATIENT SAFETY; PATIENT SELECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE FRACTIONATION; RADIATION INJURY; SKIN DISEASE; TIME; TRAVEL; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 39049102480     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2007.07.033     Document Type: Article

References (25)

1. Chopra R. The Indian scene. J Clin Oncol 19 18 Suppl (2001) 106S-111S
2. Blichert-Toft M., Rose C., Andersen J.A., et al., Danish Breast Cancer Cooperative Group. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. J Natl Cancer Inst Monogr 11 (1992) 19-25
3. Fisher B., Anderson S., Redmond C.K., et al. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 333 22 (1995) 1456-1461
4. Sarrazin D., Le M.G., Arriagada R., et al. Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol 14 3 (1989) 177-184
5. Van Dongen J.A., Voogd A.C., Fentiman I.S., et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Nat Cancer Inst 92 14 (2000) 1143-1150
6. Veronesi U., Salvadori B., Luini A., et al. Breast conservation is a safe method in patients with small cancer of the breast. Long-term results of three randomized trials on 1,973 patients. Eur J Cancer 31A 10 (1995) 1574-1579
7. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. N Engl J Med 333 22 (1995) 1444-1455
8. Morris A.D., Morris R.D., Wilson J.F., et al. Breast-conserving therapy vs. mastectomy in early-stage breast cancer: a meta-analysis of 10-year survival. Cancer J Sci Am 3 1 (1997) 6-12
9. Dinshaw K.A., Sarin R., Budrukkar A.N., et al. Safety and feasibility of breast conserving therapy in Indian women: two decades of experience at Tata Memorial Hospital. J Surg Oncol 94 2 (2006) 105-113
10. Bartelink H., Horiot J.C., Poortmans P., et al., European Organization for Research and Treatment of Cancer Radiotherapy and Breast Cancer Groups. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 345 19 (2001) 1378-1387
11. Fu K.K., Pajak T.F., Trotti A., et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyper fractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48 1 (2000) 7-16
12. Jalali R., Malde R., Sarin R., et al. Concomitant weekly tumour bed boost with whole breast irradiation in patients with locally advanced breast cancer undergoing breast conservation therapy: a prospective study. Eur J Cancer Suppl 3 2 (2005) 112
13. Aaronson N.K., Bartelink H., Van Dongen J.A., et al. Evaluation of breast conserving therapy: clinical, methodological and psychosocial perspectives. Eur J Surg Oncol 14 (1988) 133-140
14. Fleiss J.L. Statistical methods for rates and proportions. 2nd ed (1981), Wiley, New York
15. Olivotto I.A., Weir L.M., Kim-Sing C., et al. Late cosmetic results of short fractionation for breast conservation. Radiother Oncol 41 (1996) 7
16. Schomberg P.J., Shanahan T.G., Ingle J.N., et al. Accelerated hyper fractionation radiation therapy after lumpectomy and axillary lymph node dissection in patients with stage I or II breast cancer: pilot study. Radiology 202 (1997) 565
17. Shelley W., Brundage M., Hayter C., et al. A shorter fractionation schedule for post-lumpectomy breast cancer patients. Int J Radiat Oncol Biol Phys 47 (2000) 1219
18. Whelan T., MacKenzie R., Julian J., et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst 94 (2002) 1143
19. Owen J.R., Ashton A., Bliss J.M., et al. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol 7 6 (2006) 467-471
20. Bartelink H., Horiot J.C., Poortmans P., et al. Impact of radiation dose on local control, fibrosis and survival after breast conserving treatment: 10 years results of the EORTC Trial 22881-10882. Breast Cancer Res Treatment 100 Suppl 1 (2006)
21. Budrukkar A., Sarin R., Shrivastava S., et al. Local control, cosmesis and late sequelae following breast conserving therapy: influence of type of tumour bed boost and adjuvant chemotherapy. Eur J Cancer 3 2 (2005) 100
22. Jacquillat C., Weil M., Baillet F., et al. Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancer. Cancer 66 1 (1990) 119-129
23. Vrieling C., Collette L., Bartelink E., et al. Validation of the methods of cosmetic assessment after breast-conserving therapy in the EORTC "boost vs. no boost" trial. Int J Radiat Oncol Biol Phys 45 (1999) 667-676
24. Coles C., and Yarnold J. The IMPORT trials are launched. Clin Oncol 18 8 (2006) 587-590
25. Clark J., Rosenman J., Cance W., et al. Extending the indications for breast-conserving treatment to patients with locally advanced breast cancer. Int J Radiat Oncol Biol Phys 42 2 (1998) 345-350